Bajaj Finserv Healthcare Fund
Holdings
35
Concentrated
Top 10 weight
62%
Concentration
Strategy
Active
Portfolio style
Equity
97%
Asset allocation
Portfolio
9Sectors7Large positions69.2%Top: Pharmaceuticals & Biotechnology0.0%Cash
Market-cap allocation
Large cap36%
Mid cap20%
Small cap40%
Asset allocation
Equity97%
Top holdings
Divi's Laboratories LimitedEQUITY9.7%
Sun Pharmaceutical Industries LimitedEQUITY8.9%
Piramal Pharma LimitedEQUITY6.6%
Apollo Hospitals Enterprise LimitedEQUITY6.5%
Aurobindo Pharma LimitedEQUITY6.1%
Rubicon Research LimitedEQUITY6.0%
Torrent Pharmaceuticals LimitedEQUITY5.5%
Neuland Laboratories LimitedEQUITY4.4%
Emcure Pharmaceuticals LimitedEQUITY4.4%
Max Healthcare Institute LimitedEQUITY3.8%
Sign in for free to unlock all 35 holdings →Portfolio insights
Portfolio read
- 97% equity.
- Large-cap exposure is 36%.
- Largest equity sector is Pharmaceuticals & Biotechnology at 69.2%.
Watchpoints
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 69%.
Generated from current fund metrics. Educational research only.
Peer comparison
Other funds in Sectoral / Thematic.
Explore comparable funds →Sector exposure
Showing top sectors from the current portfolio.
Healthcare Services18.4%
Food Products2.7%
Sign in for free to unlock all 9 sectors →